|
RIGL Rigel Pharmaceuticals Inc 1034842 |
| Balance Sheet |
|
Current Assets
|
106,467,000 |
|
Assets
|
139,419,000 |
|
Current Liabilities
|
54,312,000 |
|
Liabilities
|
154,055,000 |
|
Equity
|
-14,636,000 |
|
Shares Out
|
17,595,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
16,968,000 |
|
Investing Cash Flow
|
15,044,000 |
| Market Analysis |
Market Cap
|
245,801,735 |
|
Price
|
20.13 |
|
BVPS
|
0.41 |
|
PB
|
49.08 |
|
EPS
|
-0.81 |
|
PS
|
1.11 |
|
FCF
|
32,012,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RIGL documents filed with the SEC.
RIGL Filings
Clear
